Baveno VI-SSM was able to stratify the risk of portal hypertension-related events in patients with HBV-related cirrhosis.
Wang H, Liang W, Zhou L, Song J, Wen B, Wu Q, Zhang Y, Zhang X, Ke H, Tang Y, Zhou F, Zhu Y, Wen W, Liu Z, Ji Y, Lai Q, He Q, Luo W, Qi T, Liu M, Lan X, Chen Y, Xi R, Wan J, Dai L, Li Y, Chen J.
Wang H, et al. Among authors: qi t.
Clin Mol Hepatol. 2025 Feb 5. doi: 10.3350/cmh.2024.0609. Online ahead of print.
Clin Mol Hepatol. 2025.
PMID: 39905841